LifeLabs Opens its Newest Patient Service Centre in Brampton, Ontario

2 years ago

LifeLabs Builds on Commitment to Deliver Accessible Community Testing to Ontarians LifeLabs Opens its Newest Patient Service Centre in Brampton,…

Allarity Therapeutics Reports First Quarter 2022 Financial Results

2 years ago

Cambridge, MA U.S.A. (May 27, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel…

New Yorker Marine Veteran Honored with 2022 Ford F-150 Vehicle

2 years ago

Wounded Warriors Family Support Presents Mobility is Freedom Donation WWFS CEO and President Kate McCauley Presents Keys to Luis Remache…

Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q

2 years ago

SAN DIEGO, May 27, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the…

ObsEva Announces Corporate Updates

2 years ago

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – May 27, 2022…

Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders

2 years ago

PRESS RELEASEREGULATED INFORMATION27 May 2022, 06:00 pm CEST Ghent, Belgium – 27 May 2022 – Sequana Medical NV (Euronext Brussels:…

Todos Medical Releases Corporate Update

2 years ago

New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a…

HealthRecon Connect Successfully Completes SOC 1® Type 2 Examination

2 years ago

DALLAS, May 27, 2022 (GLOBE NEWSWIRE) -- HealthRecon Connect, leading technology enabled revenue cycle management solutions provider to US Healthcare…

Houston Dermatologist Named President of American Society for Laser Medicine and Surgery

2 years ago

Dr. Paul M. Friedman announces plans for new philanthropic programs for the international organization. Dr. Paul Friedman President of American…

Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022

2 years ago

SAN FRANCISCO, May 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and…